← Back to Search

Pulsed Field Ablation

Safety & Performance of the Centauri System for Patients With Atrial Fibrillation (SPACE AF Trial)

N/A
Waitlist Available
Research Sponsored by Galaxy Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing the Centauri system, a device for treating irregular heartbeats by creating small scars in the heart. It targets adults aged 18-75 who need treatment for atrial fibrillation. The goal is to see if it safely and effectively stops abnormal heart signals.

Eligible Conditions
  • Atrial Fibrillation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acute Procedural Success
Chronic Success
Device and Procedure related serious adverse event rate

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Galaxy Medical, Inc.Lead Sponsor
1 Previous Clinical Trials
200 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
200 Patients Enrolled for Atrial Fibrillation
~4 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top